Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Mirum Pharmaceuticals Inc’s stock clocked out at $42.28, down -3.05% from its previous closing price of $43.61. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 0.36 million shares were traded. MIRM stock price reached its highest trading level at $43.968 during the session, while it also had its lowest trading level at $41.745.
Ratios:
To gain a deeper understanding of MIRM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.15 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 1.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 14 ’24 when Howe Jolanda sold 2,500 shares for $47.10 per share. The transaction valued at 117,752 led to the insider holds 2,426 shares of the business.
Heron Patrick J bought 115 shares of MIRM for $4,301 on Sep 18 ’24. The Director now owns 162,308 shares after completing the transaction at $37.40 per share. On Sep 06 ’24, another insider, Heron Patrick J, who serves as the Director of the company, bought 230 shares for $41.58 each. As a result, the insider paid 9,563 and bolstered with 162,193 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 2093481472 and an Enterprise Value of 2062840704. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.61 while its Price-to-Book (P/B) ratio in mrq is 8.74. Its current Enterprise Value per Revenue stands at 6.719 whereas that against EBITDA is -28.296.
Stock Price History:
Over the past 52 weeks, MIRM has reached a high of $48.89, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is 1.41%, while the 200-Day Moving Average is calculated to be 21.83%.
Shares Statistics:
It appears that MIRM traded 379.34K shares on average per day over the past three months and 326670 shares per day over the past ten days. A total of 47.97M shares are outstanding, with a floating share count of 38.27M. Insiders hold about 20.29% of the company’s shares, while institutions hold 94.36% stake in the company. Shares short for MIRM as of 1732838400 were 6717759 with a Short Ratio of 17.71, compared to 1730332800 on 6845267. Therefore, it implies a Short% of Shares Outstanding of 6717759 and a Short% of Float of 16.25.
